ABVC BioPharma (ABVC)

• Market cap: $49.6M
• 1 day: 0.49%
• 5 days: -9.33%
• 1 month: -30.14%
• 3 months: -25%
• 6 months: 5.15%
• Year to date: 218.1%
• 1 year: 320.62%
• 5 years: -93.18%
• 10 years: -93.18%
• Sector: Healthcare
• Industry: Biotechnology

About: ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.

Employees: 19